{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:35:48Z","timestamp":1780083348413,"version":"3.54.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Myasthenia gravis (MG) is an autoimmune disease related to the production of autoantibodies. It is mediated by antibodies against acetylcholine receptor (AChR), muscle specific kinase (MuSK) or other AChR related proteins in the postsynaptic muscle membrane, which interfere with the transmission of signals at the neuromuscular junction, resulting in clinical symptoms of skeletal muscle weakness and fatigue, leading to the occurrence and development of MG. At present, the incidence rate of Mg is increasing year by year. At present, the method of invigorating spleen, replenishing qi and tonifying kidney in traditional Chinese medicine has been widely used in the clinical treatment of MG, and the effect is good. The purpose of this study was to systematically evaluate the efficacy and safety of the method of invigorating the spleen, supplementing qi and tonifying the kidney in the treatment of MG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will search from the following eight databases: PubMed, Cochrane Library, EMBASE, Web of Science, CNKI, Sinomed, Wanfang, and Vip. All randomized controlled trial (RCT) literature has been searched and classified since the establishment of the database to date. In this study, two researchers independently screened and evaluated the quality of the retrieved literature. Cochrane risk bias assessment tool was used to evaluate the risk of bias. The meta-analysis uses RevMan 5.3 software provided by Cochrane Collaboration Network for meta analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study compared the main outcome indicators: clinical response rate, recurrence rate, incidence of adverse reactions, quantitative myasthenia gravis score (QMG). Secondary outcomes were clinical absolute score, quality of life score (QOL), levels of inflammatory factors such as IL-6, IL-10, and serum acetylcholine receptor antibody (AChR-Ab) levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate the efficacy and safety of the method of invigorating the spleen, supplementing qi and tonifying the kidney in treating MG, and to provide evidence based medicine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032285","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T14:03:36Z","timestamp":1671717816000},"page":"e32285","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"given":"Miao","family":"Liu","sequence":"first","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongan","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Lv","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyue","family":"Zhu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Song","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-1878","authenticated-orcid":false,"given":"Xinzhi","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical Hospital Research Institute of Jilin Academy of Chinese Medicine, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"R2-20250504","first-page":"1","article-title":"Chinese myasthenia gravis diagnosis and treatment guidelines (2020 Edition)","volume":"28","author":"Chang","year":"2021","journal-title":"Chin J Neuroimmunol Neurol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R5-20250504","article-title":"Cochrane Handbook for systematic reviews of interventions version. 6.2 (updated February 2021).","author":"Higgins","year":"2021","journal-title":"Cochrane"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10072-019-04146-1","article-title":"Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China","volume":"41","author":"Fang","year":"2020","journal-title":"Neurol Sci"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"R9-20250504","first-page":"143","article-title":"Effect of tonifying Zhong Yi Qi Tang on peripheral blood humoral immune function indices in patients with myasthenia gravis","volume":"17","author":"Zhang","year":"2017","journal-title":"World Abstract Latest Med Inf"},{"key":"R10-20250504","first-page":"69","article-title":"Efficacy of combining zhi kidney and liver tonifying soup with bromipyridamole in the treatment of myasthenia gravis","volume":"40","author":"Zhao","year":"2017","journal-title":"J Yunnan College Tradit Chin Med"},{"key":"R11-20250504","first-page":"459","article-title":"Effect of warming the kidney and strengthening the spleen formula on immune function in patients with myasthenia gravis","volume":"38","author":"Zhang","year":"2018","journal-title":"J Hunan Univ Tradit Chin Med"},{"key":"R12-20250504","first-page":"131","article-title":"Study on the effect of tonic spleen powerful formula on experimental autoimmune myasthenia gravis rats","volume":"33","author":"Wang","year":"2017","journal-title":"Chin Pharmacol Clin"},{"key":"R13-20250504","first-page":"5284","article-title":"Therapeutic effects of tonifying Zhong Yi Qi Tang and its addition of Tiger Balm on experimental autoimmune myasthenia gravis in rats","volume":"31","author":"Liu","year":"2016","journal-title":"Chin J Tradit Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:16:32Z","timestamp":1746332192000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":12,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032285","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}